STAT NewsOriginal article
STAT+: In small trial, optogenetics restores some vision lost to retinitis pigmentosa
Phase 2positiveoptogeneticsPositive
AI Analysis
Summary
A small clinical trial demonstrates that optogenetics can restore photosensitivity in approximately half of patients with retinitis pigmentosa, showing promise for this vision restoration approach.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Outcome Details
About half of patients regained photosensitivity in their vision
Importance:6/10
Sentiment:
0.70
optogeneticsretinitis pigmentosavision restorationclinical trial
Read the original article
Published by STAT News on October 7, 2026 9:00 PM